Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
+0.04 (0.45%)
At close: Dec 20, 2024, 4:00 PM
9.17
+0.16 (1.82%)
After-hours: Dec 20, 2024, 6:30 PM EST
Kura Oncology Employees
Kura Oncology had 142 employees as of December 31, 2023. The number of employees increased by 9 or 6.77% compared to the previous year.
Employees
142
Change (1Y)
9
Growth (1Y)
6.77%
Revenue / Employee
n/a
Profits / Employee
-$1,391,211
Market Cap
700.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Avanos Medical | 3,771 |
Bioventus | 970 |
Cronos Group | 356 |
Relay Therapeutics | 323 |
Evolus | 273 |
Keros Therapeutics | 136 |
Immunome | 55 |
Oculis Holding AG | 36 |
KURA News
- 2 days ago - Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade) - Seeking Alpha
- 12 days ago - Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting - GlobeNewsWire
- 19 days ago - Kura Oncology to Host Virtual Investor Event on December 9, 2024 - GlobeNewsWire
- 26 days ago - Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit - GlobeNewsWire
- 4 weeks ago - Kura Oncology to partner with Kyowa Kirin for blood cancer therapy - Reuters
- 4 weeks ago - Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias - GlobeNewsWire
- 6 weeks ago - Kura Oncology, Inc. (KURA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting - GlobeNewsWire